Overview

To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
To evaluate long-term safety and efficacy of pregabalin in the treatment of neuropathic pain after spinal cord injury.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin